Our management team has the breadth of experience and passion to bring meaningful therapies to patients with Duchenne muscular dystrophy (DMD).
Ilan Ganot Co-Founder, President and CEO
Alvaro Amorrortu Chief Operating Officer
Jorge A. Quiroz, M.D. Chief Medical Officer
Joel Schneider, Ph.D. Chief Technology Officer, Head of Exploratory Research & Development
Carl Morris, Ph.D. Chief Scientific Officer
Jennifer Ziolkowski, CPA Chief Financial Officer